Both in Pharmaceuticals
CytomX Therapeutics vs Crescent Biopharma
Over the past year CTMX returned −43.6% and CBIO returned +7.2%; their daily moves had a correlation of 0.29.
CTMX −43.6% CBIO +7.2%Growth of $1, one year, split-adjusted
| Metric | CTMX | CBIO |
|---|---|---|
| Price | $2.22 | $13.24 |
| Market cap | $482.6M | $491.6M |
| Today | −0.67% | +2.52% |
| 1 month | −14.1% | −5.1% |
| 6 months | −45.7% | −26.8% |
| Year to date | −48.0% | +11.6% |
| 1 year | −38.0% | +3.8% |
| Revenue growth (YoY) | −92.4% | — |
| Gross margin | 100.0% | — |
| Net margin | −1457.4% | — |
| P/E (TTM) | — | — |
| Price / sales | 26.4× | 41.4× |
| Net cash | $330.3M | $171.6M |
| Dividend yield | — | — |
| Volatility (60d) | 67.5% | 69.1% |
| Short % of float | 21.4% | 21.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).